Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

A Functional Bioluminescent Zebrafish Screen for Enhancing Hematopoietic Cell Homing.

Astuti Y, Kramer AC, Blake AL, Blazar BR, Tolar J, Taisto ME, Lund TC.

Stem Cell Reports. 2017 Jan 10;8(1):177-190. doi: 10.1016/j.stemcr.2016.12.004. Epub 2016 Dec 29.

2.

Repurposing Treprostinil for Enhancing Hematopoietic Progenitor Cell Transplantation.

Kazemi Z, Bergmayr C, Prchal-Murphy M, Javaheri T, Themanns M, Pham HT, Strohmaier W, Sexl V, Freissmuth M, Zebedin-Brandl E.

Mol Pharmacol. 2016 Jun;89(6):630-44. doi: 10.1124/mol.116.103267. Epub 2016 Mar 17.

3.

Regulatory Interactions in the Bone Marrow Microenvironment.

Smith JN, Calvi LM.

IBMS Bonekey. 2011;8(2):96-111.

4.

TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration.

Zhang Y, Desai A, Yang SY, Bae KB, Antczak MI, Fink SP, Tiwari S, Willis JE, Williams NS, Dawson DM, Wald D, Chen WD, Wang Z, Kasturi L, Larusch GA, He L, Cominelli F, Di Martino L, Djuric Z, Milne GL, Chance M, Sanabria J, Dealwis C, Mikkola D, Naidoo J, Wei S, Tai HH, Gerson SL, Ready JM, Posner B, Willson JK, Markowitz SD.

Science. 2015 Jun 12;348(6240):aaa2340. doi: 10.1126/science.aaa2340.

5.

Getting more for your marrow: boosting hematopoietic stem cell numbers with PGE2.

Hagedorn EJ, Durand EM, Fast EM, Zon LI.

Exp Cell Res. 2014 Dec 10;329(2):220-6. doi: 10.1016/j.yexcr.2014.07.030. Epub 2014 Aug 2. Review.

6.

Minireview: complexity of hematopoietic stem cell regulation in the bone marrow microenvironment.

Hoffman CM, Calvi LM.

Mol Endocrinol. 2014 Oct;28(10):1592-601. doi: 10.1210/me.2014-1079. Epub 2014 Aug 1. Review.

7.

Cellular complexity of the bone marrow hematopoietic stem cell niche.

Calvi LM, Link DC.

Calcif Tissue Int. 2014 Jan;94(1):112-24. doi: 10.1007/s00223-013-9805-8. Epub 2013 Oct 8. Review.

8.

Osteoclasts and hematopoiesis.

Teti A.

Bonekey Rep. 2012 Mar 28;1:46. doi: 10.1038/bonekey.2012.46. eCollection 2012.

9.

The multiple faces of prostaglandin E2 G-protein coupled receptor signaling during the dendritic cell life cycle.

De Keijzer S, Meddens MB, Torensma R, Cambi A.

Int J Mol Sci. 2013 Mar 25;14(4):6542-55. doi: 10.3390/ijms14046542. Review.

10.

Concise review: Current concepts in bone marrow microenvironmental regulation of hematopoietic stem and progenitor cells.

Smith JN, Calvi LM.

Stem Cells. 2013 Jun;31(6):1044-50. doi: 10.1002/stem.1370. Review.

11.

Proteins and small molecules for cellular regenerative medicine.

Green EM, Lee RT.

Physiol Rev. 2013 Jan;93(1):311-25. doi: 10.1152/physrev.00005.2012. Review.

12.

Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injury.

Porter RL, Georger MA, Bromberg O, McGrath KE, Frisch BJ, Becker MW, Calvi LM.

Stem Cells. 2013 Feb;31(2):372-83. doi: 10.1002/stem.1286.

13.

The regulation of normal and leukemic hematopoietic stem cells by niches.

Huang MM, Zhu J.

Cancer Microenviron. 2012 Dec;5(3):295-305. doi: 10.1007/s12307-012-0114-y. Epub 2012 Jul 22.

14.

Bone marrow-derived matrix metalloproteinase-9 is associated with fibrous adhesion formation after murine flexor tendon injury.

Loiselle AE, Frisch BJ, Wolenski M, Jacobson JA, Calvi LM, Schwarz EM, Awad HA, O'Keefe RJ.

PLoS One. 2012;7(7):e40602. doi: 10.1371/journal.pone.0040602. Epub 2012 Jul 11.

15.

Dual actions of Meis1 inhibit erythroid progenitor development and sustain general hematopoietic cell proliferation.

Cai M, Langer EM, Gill JG, Satpathy AT, Albring JC, KC W, Murphy TL, Murphy KM.

Blood. 2012 Jul 12;120(2):335-46. doi: 10.1182/blood-2012-01-403139. Epub 2012 Jun 4.

16.

Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells.

Bromberg O, Frisch BJ, Weber JM, Porter RL, Civitelli R, Calvi LM.

Blood. 2012 Jul 12;120(2):303-13. doi: 10.1182/blood-2011-09-377853. Epub 2012 May 17.

17.

Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CML.

Heidel FH, Bullinger L, Feng Z, Wang Z, Neff TA, Stein L, Kalaitzidis D, Lane SW, Armstrong SA.

Cell Stem Cell. 2012 Apr 6;10(4):412-24. doi: 10.1016/j.stem.2012.02.017.

18.

Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia.

Frisch BJ, Ashton JM, Xing L, Becker MW, Jordan CT, Calvi LM.

Blood. 2012 Jan 12;119(2):540-50. doi: 10.1182/blood-2011-04-348151. Epub 2011 Sep 28.

19.

The niche as a target for hematopoietic manipulation and regeneration.

Lawal RA, Calvi LM.

Tissue Eng Part B Rev. 2011 Dec;17(6):415-22. doi: 10.1089/ten.TEB.2011.0197. Epub 2011 Sep 27. Review.

20.

Pleiotropic effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and other eicosanoids regulate hematopoietic stem and progenitor cell function.

Pelus LM, Hoggatt J.

Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):3-9. doi: 10.1016/j.prostaglandins.2011.06.004. Epub 2011 Jun 21. Review.

Supplemental Content

Support Center